Literature DB >> 6359

The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer.

C T Richardson, J H Walsh, M I Hicks.   

Abstract

Meal-stimulated acid secretion, measured by in vivo intragastric titration, was progressively inhibited by increasing oral doses of cimetidine (25 to 400 mg). Four hundred milligrams suppressed acid secretion by 73% for the first 3 hr after the meal, whereas it inhibited acid secretion by 94% during the 30-min period of maximal inhibition. The dose of cimetidine required to suppress acid secretion by 50% during the 30-min period of maximal inhibition was 25 mg. The duration of action of a 300-mg dose was at least 7 hr. Cimetidine was equally effective in inhibiting meal-stimulated acid secretion at two physiological intragastric pH levels (5.0 and 2.5). Cimetidine had no effect on serum gastrin concentration when intragastric pH was maintained at 5.0, but when pH was allowed to seek its own level, serum gastrin concentration was higher after cimetidine than after placebo. Cimetidine had no effect on gastric emptying. No side effects were noted in any patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6359

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Influence of acid-pepsin secretion on gastric emptying of solids in humans: studies with cimetidine.

Authors:  D D Kerrigan; Y F Mangnall; N W Read; A G Johnson
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

2.  Internal medicine-epitomes of progress: cimetidine in the treatment of peptic ulcer disease.

Authors:  J P Cello
Journal:  West J Med       Date:  1978-07

3.  Metiamide: more than an H2-receptor antagonist.

Authors:  D A Simay; G W Peskin; R P Saik
Journal:  Am J Dig Dis       Date:  1978-02

4.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Cimetidine and postprandial pancreatic exocrine secretion in dogs.

Authors:  J A Madrid; G M Salido; E Martinez de Victoria; F J Mataix
Journal:  Agents Actions       Date:  1985-12

6.  Evaluation of two equivalent regimens (BID, QID) of cimetidine to raise intragastric pH over a 24-hour period in patients with duodenal ulcer.

Authors:  K Shiratori; S Watanabe; T Takeuchi
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

7.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

8.  Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.

Authors:  R Mohammed; R J Holden; J B Hearns; B M McKibben; K D Buchanan; G P Crean
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

9.  Inhibitory effect of cimetidine on gastric acid secretion vagally activated by physiological means in duodenal ulcer patients.

Authors:  I M Schöön; L Olbe
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

10.  Effects of preoperative medications on gastric pH, volume, and flora.

Authors:  H L Laws; J W Bryant; M D Palmer; A M Boudreaux; J M Donald; A S Wheeler
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.